Efficacy and safety of long-term use of tedizolid in disseminated nocardiosis after heart transplantation

Transpl Infect Dis. 2024 Feb;26(1):e14174. doi: 10.1111/tid.14174. Epub 2023 Oct 17.

Authors

Miguel Sogbe^{1

2}, Madeleine Di Frisco³, José Luis Del Pozo^{1

4

5}

Affiliations

¹ Infectious Diseases Division, Clínica Universidad de Navarra, Pamplona, Spain.
² Internal Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain.
³ Pulmonary Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain.
⁴ IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
⁵ Microbiology Department, Clínica Universidad de Navarra, Pamplona, Spain.

PMID: 37846883
DOI: 10.1111/tid.14174

No abstract available

Keywords: disseminated; heart transplantation; nocardiosis; tedizolid.

MeSH terms

Anti-Bacterial Agents / therapeutic use
Heart Transplantation* / adverse effects
Humans
Nocardia Infections* / diagnosis
Nocardia Infections* / drug therapy
Nocardia*
Oxazolidinones* / adverse effects
Tetrazoles

Substances

tedizolid
Oxazolidinones
Tetrazoles
Anti-Bacterial Agents